These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 3409505)

  • 21. Endogenous prostaglandin endoperoxides and prostacyclin modulate the thrombolytic activity of tissue plasminogen activator. Effects of simultaneous inhibition of thromboxane A2 synthase and blockade of thromboxane A2/prostaglandin H2 receptors in a canine model of coronary thrombosis.
    Golino P; Rosolowsky M; Yao SK; McNatt J; De Clerck F; Buja LM; Willerson JT
    J Clin Invest; 1990 Oct; 86(4):1095-102. PubMed ID: 2145320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemia.
    Grover GJ; Schumacher WA
    Basic Res Cardiol; 1989; 84(1):103-10. PubMed ID: 2522297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and alpha-adrenergic receptors.
    Apprill P; Schmitz JM; Campbell WB; Tilton G; Ashton J; Raheja S; Buja LM; Willerson JT
    Circulation; 1985 Aug; 72(2):397-405. PubMed ID: 2988822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of serotonin in thrombogenesis.
    De Clerck F
    Clin Physiol Biochem; 1990; 8 Suppl 3():40-9. PubMed ID: 1966729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits.
    Valentin JP; Vieu S; Bertolino F; Fauré P; John GW
    J Pharmacol Exp Ther; 1997 Feb; 280(2):761-9. PubMed ID: 9023289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclic flow variations in a conscious dog model of coronary artery stenosis and endothelial injury correlate with acute ischemic heart disease syndromes in humans.
    Ikeda H; Koga Y; Kuwano K; Nakayama H; Ueno T; Yoshida N; Adachi K; Park IS; Toshima H
    J Am Coll Cardiol; 1993 Mar; 21(4):1008-17. PubMed ID: 8450149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage.
    Kirchengast M; Rübsamen K; Lehmann HD
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):687-94. PubMed ID: 7506319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury.
    Willerson JT; Yao SK; McNatt J; Benedict CR; Anderson HV; Golino P; Murphree SS; Buja LM
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10624-8. PubMed ID: 1961728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation.
    Pakala R; Willerson JT; Benedict CR
    Circulation; 1997 Oct; 96(7):2280-6. PubMed ID: 9337201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries.
    Bush LR; Campbell WB; Buja LM; Tilton GD; Willerson JT
    Circulation; 1984 Jun; 69(6):1161-70. PubMed ID: 6546902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The in vivo antiplatelet effects of thromboxane A2 synthase inhibitors are potentiated by simultaneous thromboxane A2/prostaglandin H2 receptor blockade.
    Golino P; Ambrosio G; Gresele P; Pascucci I; Ragni M; Russolillo E; Leproux GB; Chiariello M
    J Pharmacol Exp Ther; 1993 Aug; 266(2):511-7. PubMed ID: 8355187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
    Beaughard M; Brasset M; John G; Massingham R
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):577-83. PubMed ID: 8569218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury.
    Eidt JF; Ashton J; Golino P; McNatt J; Buja LM; Willerson JT
    J Clin Invest; 1989 Aug; 84(2):517-27. PubMed ID: 2760199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of platelet-derived 5-hydroxytryptamine in thromboxane A2-induced aggregation in cat platelets.
    Ogawa T; Sugidachi A; Asai F; Koike H
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):233-40. PubMed ID: 9663705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective actions of a thromboxane receptor antagonist, SQ 29548 on the ischemic myocardium: morphologic and hemodynamic effects.
    Singh J; Seth SD; Manchanda SC; Seth S
    Prostaglandins Leukot Essent Fatty Acids; 1997 Feb; 56(2):105-10. PubMed ID: 9051718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.
    Johnson GJ; Leis LA; Dunlop PC
    J Clin Invest; 1993 Nov; 92(5):2469-79. PubMed ID: 8227362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
    Bertolino F; Valentin JP; Maffre M; Grelac F; Bessac AM; Maclouf J; Delhon A; Lévy-Toledano S; Patoiseau JF; Colpaert FC
    Br J Pharmacol; 1995 May; 115(1):210-6. PubMed ID: 7647979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of thromboxane A2 in the control of myocardial O2 supply/consumption balance and severity of ischemia during pacing-induced ischemia.
    Grover GJ; Parham CS
    Circ Res; 1989 Mar; 64(3):575-82. PubMed ID: 2917381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries.
    Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F
    Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of acute platelet thrombosis formation in stenosed canine coronary arteries by specific serotonin 5HT2 receptor antagonist ritanserin.
    Torr S; Noble MI; Folts JD
    Cardiovasc Res; 1990 Jun; 24(6):465-70. PubMed ID: 2117499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.